4区 医学 Q3 Nursing Endocrinologia, Diabetes y Nutricion Pub Date : 2025-03-01 DOI:10.1016/j.endinu.2024.09.006
Ricard Onieva Carbajo , Joan Carles Ferreres Piñas , Flavia Alberto , Ismael Capel Flores , Martina Pérez , María Rosa Bella Cueto
{"title":"Estudio de la altura de las células en el subtipo de célula alta del carcinoma papilar de tiroides. ¿Es un factor clave en el pronóstico?","authors":"Ricard Onieva Carbajo ,&nbsp;Joan Carles Ferreres Piñas ,&nbsp;Flavia Alberto ,&nbsp;Ismael Capel Flores ,&nbsp;Martina Pérez ,&nbsp;María Rosa Bella Cueto","doi":"10.1016/j.endinu.2024.09.006","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>The tall cell subtype of papillary thyroid carcinoma (PTC) is considered to have poor prognosis, but its diagnostic criteria have been modified on several occasions. The aim of our study was to find the best diagnostic criteria to relate the tall cell subtype with aggressiveness and poor prognosis.</div></div><div><h3>Material and methods</h3><div>In 171 cases of classic subtype and tall cell subtype of PTC, the percentage of cells between two and three times taller than wide (C2-3) and cells more than three times taller than wide (Cx3) was determined by two observers, after obtaining reference images. Groups were made based on the percentage of cells of each component (&lt;2%, between 2 and 10%, between 11 and 30%, between 31 and 50% and &gt;<!--> <!-->50%) and were correlated with clinical and histopathological data. Interobserver agreement was also assessed.</div></div><div><h3>Results</h3><div>According to the current WHO classification criteria, only 8 cases (5%) of tall cell subtype were identified. The comparison of the risk of recurrence at 5 years based on the percentage and type of cells showed that it increased significantly from &gt;<!--> <!-->10% of the Cx3 cell component, while there were no significant differences in recurrence rate with any C2-3 cell percentages. Very good interobserver agreement was obtained (Kappa index: 0.83).</div></div><div><h3>Conclusions</h3><div>We consider relevant reporting the presence of Cx3 cells from 10% in PTC as it is associated with a significant increase in the recurrence rate at 5 years. Interobserver agreement is very good if reference images are available.</div></div>","PeriodicalId":37725,"journal":{"name":"Endocrinologia, Diabetes y Nutricion","volume":"72 3","pages":"Article 101530"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endocrinologia, Diabetes y Nutricion","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2530016424001976","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Nursing","Score":null,"Total":0}
引用次数: 0

摘要

导言甲状腺乳头状癌(PTC)的高细胞亚型被认为预后较差,但其诊断标准曾多次被修改。材料与方法 在171例典型亚型和高细胞亚型PTC病例中,在获得参考图像后,由两名观察者确定高度比宽度高2至3倍(C2-3)和高度比宽度高3倍以上(Cx3)的细胞百分比。根据各组细胞的百分比进行分组(2%、2-10%、11-30%、31-50% 和 50%),并与临床和组织病理学数据相关联。结果根据目前的世卫组织分类标准,仅发现 8 例(5%)高细胞亚型病例。根据细胞的百分比和类型对 5 年后的复发风险进行比较后发现,Cx3 细胞成分在 > 10% 以上的复发风险显著增加,而任何 C2-3 细胞百分比的复发率均无显著差异。结论我们认为,在 PTC 中,Cx3 细胞的比例从 10% 开始就应该报告,因为它与 5 年复发率的显著增加有关。如果有参考图像,观察者之间的一致性非常好。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Estudio de la altura de las células en el subtipo de célula alta del carcinoma papilar de tiroides. ¿Es un factor clave en el pronóstico?

Introduction

The tall cell subtype of papillary thyroid carcinoma (PTC) is considered to have poor prognosis, but its diagnostic criteria have been modified on several occasions. The aim of our study was to find the best diagnostic criteria to relate the tall cell subtype with aggressiveness and poor prognosis.

Material and methods

In 171 cases of classic subtype and tall cell subtype of PTC, the percentage of cells between two and three times taller than wide (C2-3) and cells more than three times taller than wide (Cx3) was determined by two observers, after obtaining reference images. Groups were made based on the percentage of cells of each component (<2%, between 2 and 10%, between 11 and 30%, between 31 and 50% and > 50%) and were correlated with clinical and histopathological data. Interobserver agreement was also assessed.

Results

According to the current WHO classification criteria, only 8 cases (5%) of tall cell subtype were identified. The comparison of the risk of recurrence at 5 years based on the percentage and type of cells showed that it increased significantly from > 10% of the Cx3 cell component, while there were no significant differences in recurrence rate with any C2-3 cell percentages. Very good interobserver agreement was obtained (Kappa index: 0.83).

Conclusions

We consider relevant reporting the presence of Cx3 cells from 10% in PTC as it is associated with a significant increase in the recurrence rate at 5 years. Interobserver agreement is very good if reference images are available.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Endocrinologia, Diabetes y Nutricion
Endocrinologia, Diabetes y Nutricion Nursing-Nutrition and Dietetics
CiteScore
2.10
自引率
0.00%
发文量
169
审稿时长
35 days
期刊介绍: Endocrinología, Diabetes y Nutrición is the official journal of the Spanish Society of Endocrinology and Nutrition (Sociedad Española de Endocrinología y Nutrición, SEEN) and the Spanish Society of Diabetes (Sociedad Española de Diabetes, SED), and was founded in 1954. The aim of the journal is to improve knowledge and be a useful tool in practice for clinical and laboratory specialists, trainee physicians, researchers, and nurses interested in endocrinology, diabetes, nutrition and related disciplines. It is an international journal published in Spanish (print and online) and English (online), covering different fields of endocrinology and metabolism, including diabetes, obesity, and nutrition disorders, as well as the most relevant research produced mainly in Spanish language territories. The quality of the contents is ensured by a prestigious national and international board, and by a selected panel of specialists involved in a rigorous peer review. The result is that only manuscripts containing high quality research and with utmost interest for clinicians and professionals related in the field are published. The Journal publishes Original clinical and research articles, Reviews, Special articles, Clinical Guidelines, Position Statements from both societies and Letters to the editor. Endocrinología, Diabetes y Nutrición can be found at Science Citation Index Expanded, Medline/PubMed and SCOPUS.
期刊最新文献
Hyperglycemia-related risk factors in enteral nutrition in non-critically ill patients Estudio de la altura de las células en el subtipo de célula alta del carcinoma papilar de tiroides. ¿Es un factor clave en el pronóstico? Short bowel syndrome and d-lactic acidosis: A case report with supplemental home parenteral nutrition and teduglutide Recomendaciones de la Sociedad Española de Endocrinología y Nutrición (SEEN) sobre «qué no hacer» en la práctica clínica Addendum a «La importancia de la técnica MLPA en el diagnóstico de la neoplasia endocrina múltiple tipo 1», Endocrinología, Diabetes y Nutrición 71 (2024) 221-225
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1